Literature DB >> 33614298

Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study.

Bilge Sumbul1, Hilmi Erdem Sumbul2, Ramazan Azim Okyay3, Erdinç Gülümsek2, Ahmet Rıza Şahin4, Baris Boral5, Burhan Fatih Koçyiğit6, Mostafa Alfishawy7, Jeffrey Gold8, Alİ Muhittin Tasdogan9.   

Abstract

BACKGROUND: There is growing evidence indicating that children are less affected from COVID-19. Some authors speculate that childhood vaccinations may provide some cross-protection against COVID-19. In this study, our aim was to compare the circulating antibody titers for multiple childhood vaccine antigens, as an indicator of the state of immune memory between patients with COVID-19 and healthy controls, with a specific aim to identify the association between disease severity and antibody titrations which may indicate a protective function related to vaccine or disease induced memory.
METHODS: This study is a case-control study including 53 patients with COVID-19 and 40 healthy volunteers. COVID-19 severity was divided into three groups: asymptomatic, mild and severe. We measured the same set of antibody titers for vaccine antigens, and a set of biochemical and infection markers, in both the case and control groups.
RESULTS: Rubella (p = 0.003), pneumococcus (p = 0.002), and Bordetella pertussis (p < 0.0001) titers were found to be significantly lower in the case group than the control group. There was a significant decline in pneumococcus titers with severity of disease (p = 0.021) and a significant association with disease severity for Bordetella pertussis titers (p = 0.014) among COVID patients. Levels of AST, procalcitonin, ferritin and D-dimer significantly increased with the disease severity. DISCUSSION: Our study supports the hypothesis that pre-existing immune memory, as monitored using circulating antibodies, acquired from childhood vaccinations, or past infections confer some protection against COVID-19. Randomized controlled studies are needed to support a definitive conclusion.
© 2021 Sumbul et al.

Entities:  

Keywords:  Antibody titers; COVID-19; Cross-protection; Pandemic

Year:  2021        PMID: 33614298      PMCID: PMC7879941          DOI: 10.7717/peerj.10910

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  30 in total

Review 1.  Trained immunity: A program of innate immune memory in health and disease.

Authors:  Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

2.  SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.

Authors:  Yijin Wang; Shuhong Liu; Hongyang Liu; Wei Li; Fang Lin; Lina Jiang; Xi Li; Pengfei Xu; Lixin Zhang; Lihua Zhao; Yun Cao; Jiarui Kang; Jianfa Yang; Ling Li; Xiaoyan Liu; Yan Li; Ruifang Nie; Jinsong Mu; Fengmin Lu; Shousong Zhao; Jiangyang Lu; Jingmin Zhao
Journal:  J Hepatol       Date:  2020-05-11       Impact factor: 25.083

3.  Co-infection with respiratory pathogens among COVID-2019 cases.

Authors:  Xiaojuan Zhu; Yiyue Ge; Tao Wu; Kangchen Zhao; Yin Chen; Bin Wu; Fengcai Zhu; Baoli Zhu; Lunbiao Cui
Journal:  Virus Res       Date:  2020-05-11       Impact factor: 3.303

Review 4.  Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases.

Authors:  Stéphane Cauchi; Camille Locht
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

5.  COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.

Authors:  Luca Spiezia; Annalisa Boscolo; Francesco Poletto; Lorenzo Cerruti; Ivo Tiberio; Elena Campello; Paolo Navalesi; Paolo Simioni
Journal:  Thromb Haemost       Date:  2020-04-21       Impact factor: 5.249

6.  Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.

Authors:  Yong Gao; Tuantuan Li; Mingfeng Han; Xiuyong Li; Dong Wu; Yuanhong Xu; Yulin Zhu; Yan Liu; Xiaowu Wang; Linding Wang
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 2.327

Review 7.  Mechanism of thrombocytopenia in COVID-19 patients.

Authors:  Panyang Xu; Qi Zhou; Jiancheng Xu
Journal:  Ann Hematol       Date:  2020-04-15       Impact factor: 3.673

8.  Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Clin Chim Acta       Date:  2020-03-04       Impact factor: 3.786

9.  Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.

Authors:  Jeffrey E Gold; William H Baumgartl; Ramazan A Okyay; Warren E Licht; Paul L Fidel; Mairi C Noverr; Larry P Tilley; David J Hurley; Balázs Rada; John W Ashford
Journal:  mBio       Date:  2020-11-20       Impact factor: 7.867

10.  Hematological findings and complications of COVID-19.

Authors:  Evangelos Terpos; Ioannis Ntanasis-Stathopoulos; Ismail Elalamy; Efstathios Kastritis; Theodoros N Sergentanis; Marianna Politou; Theodora Psaltopoulou; Grigoris Gerotziafas; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2020-05-23       Impact factor: 13.265

View more
  5 in total

Review 1.  An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota.

Authors:  Shaoshuai Li; Yang Zhou; Dongmei Yan; Yanmin Wan
Journal:  Viruses       Date:  2022-08-15       Impact factor: 5.818

2.  Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity.

Authors:  Liqiu Jia; Shufeng Weng; Jing Wu; Xiangxiang Tian; Yifan Zhang; Xuyang Wang; Jing Wang; Dongmei Yan; Wanhai Wang; Fang Fang; Zhaoqin Zhu; Chao Qiu; Wenhong Zhang; Ying Xu; Yanmin Wan
Journal:  Gut Microbes       Date:  2022 Jan-Dec

3.  So Few COVID-19 Cases in Taiwan: Has Population Immune Health Played a Role?

Authors:  Wen-Ta Chiu; Jeremiah Scholl; Yu-Chuan Jack Li; Jonathan Wu
Journal:  Front Public Health       Date:  2021-06-14

4.  Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.

Authors:  Raed Ibrahim Altulayhi; Rakan M Alqahtani; Reem Abdullah Alakeel; Faten Abdulrahman Khorshid; Rehab Hamoud Alshammari; Sana Ghazi Alattas; Fahad Abdullah M Alshammari; May Bin-Jumah; Mohamed M Abdel-Daim; Mohammad Almohideb
Journal:  Environ Sci Pollut Res Int       Date:  2021-06-29       Impact factor: 5.190

5.  Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths.

Authors:  Robert Root-Bernstein
Journal:  Vaccines (Basel)       Date:  2021-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.